| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 108.09B | 105.71B | 102.47B | 95.23B | 88.51B | 85.93B |
| Gross Profit | 31.37B | 30.66B | 29.92B | 27.18B | 24.13B | 24.49B |
| EBITDA | 7.22B | 7.80B | 8.03B | 6.32B | 3.53B | 4.08B |
| Net Income | 3.49B | 3.51B | 3.69B | 2.56B | 720.00M | 1.39B |
Balance Sheet | ||||||
| Total Assets | 93.68B | 95.76B | 92.61B | 85.87B | 80.92B | 77.73B |
| Cash, Cash Equivalents and Short-Term Investments | 9.37B | 8.21B | 9.63B | 9.74B | 10.34B | 10.36B |
| Total Debt | 10.78B | 10.62B | 6.79B | 6.70B | 7.09B | 6.76B |
| Total Liabilities | 45.95B | 47.38B | 46.84B | 44.97B | 42.63B | 39.64B |
| Stockholders Equity | 47.39B | 48.05B | 45.43B | 40.61B | 38.01B | 37.83B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -2.65B | 1.61B | 391.00M | 1.29B | 1.89B |
| Operating Cash Flow | 0.00 | 2.47B | 5.29B | 3.60B | 4.96B | 4.16B |
| Investing Cash Flow | 0.00 | -4.77B | -3.90B | -3.27B | -4.02B | -3.11B |
| Financing Cash Flow | 0.00 | 842.00M | -1.57B | -934.00M | -1.06B | -987.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | ¥34.93B | 7.75 | ― | 3.59% | 7.84% | 29.36% | |
77 Outperform | ¥43.22B | 14.89 | ― | 3.74% | 4.73% | 17.57% | |
66 Neutral | ¥104.03B | 13.03 | ― | 3.53% | -1.02% | -40.96% | |
66 Neutral | ¥123.00B | 10.42 | 12.89% | 3.40% | 2.68% | 23.60% | |
65 Neutral | ¥9.12B | 6.40 | ― | 3.73% | 3.28% | -69.05% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
63 Neutral | ¥5.77B | 4.98 | ― | 4.13% | 4.55% | -12.71% |